11-17495633-C-T
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_153676.4(USH1C):c.2591G>A(p.Arg864Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000669 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_153676.4 missense
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 1CInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
- autosomal recessive nonsyndromic hearing loss 18AInheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nonsyndromic genetic hearing lossInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| USH1C | NM_153676.4 | c.2591G>A | p.Arg864Gln | missense_variant | Exon 26 of 27 | ENST00000005226.12 | NP_710142.1 | |
| USH1C | NM_005709.4 | c.1646+1125G>A | intron_variant | Intron 20 of 20 | ENST00000318024.9 | NP_005700.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| USH1C | ENST00000005226.12 | c.2591G>A | p.Arg864Gln | missense_variant | Exon 26 of 27 | 5 | NM_153676.4 | ENSP00000005226.7 | ||
| USH1C | ENST00000318024.9 | c.1646+1125G>A | intron_variant | Intron 20 of 20 | 1 | NM_005709.4 | ENSP00000317018.4 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152206Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000139 AC: 35AN: 251486 AF XY: 0.000155 show subpopulations
GnomAD4 exome AF: 0.0000664 AC: 97AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.0000633 AC XY: 46AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74364 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
- -
not specified Benign:1
p.Arg864Gln in exon 26 of USH1C: This variant is not expected to have clinical s ignificance due to a lack of conservation across species, including mammals. Of note, Tibetan antelope, domestic goat, cat, elephant, manatee, and tenrec have a glutamine at this position despite high nearby amino acid conservation. In addi tion, additional computational prediction tools do not suggest a high likelihood of impact to the protein. This variant has also been identified in 0.02% (2/858 6) of European American chromosomes by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS/; dbSNP rs374696855). -
USH1C-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at